Advertisement

Topics

ArQule to Present at The JMP Securities Life Sciences Conference on June 21, 2018

07:00 EDT 14 Jun 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
ArQule, Inc. (Nasdaq: ARQL) today announced that Paolo Pucci, Chief Executive Officer, and Dr. Brian Schwartz, Chief Medical Officer and Head of Research and Development, will present at The JMP Securities Life Sciences Conferen...

Other Sources for this Article

Corporate Contact:
ArQule, Inc.
Marc Schegerin, M.D., 781-994-0440
Senior Vice President, Strategy, Communication and Finance
marc@arqule.com
www.ArQule.com
or
Media Contact:
LifeSci Public Relations
Allison Blum, Ph.D., 646-627-8383
Allison@lifescipublicrelations.com

NEXT ARTICLE

More From BioPortfolio on "ArQule to Present at The JMP Securities Life Sciences Conference on June 21, 2018"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...